ADI, autophagy and apoptosis: Metabolic stress as a therapeutic option for prostate cancer

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Prostate cancer, the leading incidence of cancer in American males, is a disease in which treatment of nonlocalized tumors remains largely unsuccessful. These cancers lose expression of an arginine synthesis enzyme, argininosuccinate synthetase (ASS), and are susceptible to arginine deprivation by arginine deiminase (ADI). We show CWR22Rv1 prostate cancer cells are susceptible to ADI in a caspase-independent manner in vitro and in a xenograft model in vivo. We demonstrate that single amino acid deprivation by ADI is able to trigger autophagy. Inhibition of autophagy by chloroquine and siRNA enhances and accelerates ADI-induced cell death, suggesting that autophagy is a protective response to ADI, at least in the early phases. In addition, the co-administration of docetaxel, a caspase-dependent chemotherapy, with ADI inhibits tumor growth in vivo. Thus, targeting multiple cell death pathways, either through autophagy modulation or non-canonical apoptosis, may find expanded use as adjuvant chemotherapies, providing additional avenues for cancer treatment.

Original languageEnglish (US)
Pages (from-to)567-568
Number of pages2
JournalAutophagy
Volume5
Issue number4
DOIs
StatePublished - May 16 2009

Fingerprint

Physiological Stress
Autophagy
Prostatic Neoplasms
Apoptosis
docetaxel
Neoplasms
Caspases
Arginine
Cell Death
Therapeutics
Argininosuccinate Synthase
Chloroquine
Adjuvant Chemotherapy
Heterografts
Small Interfering RNA
arginine deiminase
Amino Acids
Drug Therapy
Incidence
Enzymes

Keywords

  • Arginine deiminase
  • Arginine deprivation
  • Autophagy
  • Caspase-independent apoptosis
  • Prostate cancer

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

ADI, autophagy and apoptosis : Metabolic stress as a therapeutic option for prostate cancer. / Kim, Randie H.; Bold, Richard J; Kung, Hsing-Jien.

In: Autophagy, Vol. 5, No. 4, 16.05.2009, p. 567-568.

Research output: Contribution to journalArticle

@article{edc6c367cebd482a85492571248043c4,
title = "ADI, autophagy and apoptosis: Metabolic stress as a therapeutic option for prostate cancer",
abstract = "Prostate cancer, the leading incidence of cancer in American males, is a disease in which treatment of nonlocalized tumors remains largely unsuccessful. These cancers lose expression of an arginine synthesis enzyme, argininosuccinate synthetase (ASS), and are susceptible to arginine deprivation by arginine deiminase (ADI). We show CWR22Rv1 prostate cancer cells are susceptible to ADI in a caspase-independent manner in vitro and in a xenograft model in vivo. We demonstrate that single amino acid deprivation by ADI is able to trigger autophagy. Inhibition of autophagy by chloroquine and siRNA enhances and accelerates ADI-induced cell death, suggesting that autophagy is a protective response to ADI, at least in the early phases. In addition, the co-administration of docetaxel, a caspase-dependent chemotherapy, with ADI inhibits tumor growth in vivo. Thus, targeting multiple cell death pathways, either through autophagy modulation or non-canonical apoptosis, may find expanded use as adjuvant chemotherapies, providing additional avenues for cancer treatment.",
keywords = "Arginine deiminase, Arginine deprivation, Autophagy, Caspase-independent apoptosis, Prostate cancer",
author = "Kim, {Randie H.} and Bold, {Richard J} and Hsing-Jien Kung",
year = "2009",
month = "5",
day = "16",
doi = "10.4161/auto.5.4.8252",
language = "English (US)",
volume = "5",
pages = "567--568",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - ADI, autophagy and apoptosis

T2 - Metabolic stress as a therapeutic option for prostate cancer

AU - Kim, Randie H.

AU - Bold, Richard J

AU - Kung, Hsing-Jien

PY - 2009/5/16

Y1 - 2009/5/16

N2 - Prostate cancer, the leading incidence of cancer in American males, is a disease in which treatment of nonlocalized tumors remains largely unsuccessful. These cancers lose expression of an arginine synthesis enzyme, argininosuccinate synthetase (ASS), and are susceptible to arginine deprivation by arginine deiminase (ADI). We show CWR22Rv1 prostate cancer cells are susceptible to ADI in a caspase-independent manner in vitro and in a xenograft model in vivo. We demonstrate that single amino acid deprivation by ADI is able to trigger autophagy. Inhibition of autophagy by chloroquine and siRNA enhances and accelerates ADI-induced cell death, suggesting that autophagy is a protective response to ADI, at least in the early phases. In addition, the co-administration of docetaxel, a caspase-dependent chemotherapy, with ADI inhibits tumor growth in vivo. Thus, targeting multiple cell death pathways, either through autophagy modulation or non-canonical apoptosis, may find expanded use as adjuvant chemotherapies, providing additional avenues for cancer treatment.

AB - Prostate cancer, the leading incidence of cancer in American males, is a disease in which treatment of nonlocalized tumors remains largely unsuccessful. These cancers lose expression of an arginine synthesis enzyme, argininosuccinate synthetase (ASS), and are susceptible to arginine deprivation by arginine deiminase (ADI). We show CWR22Rv1 prostate cancer cells are susceptible to ADI in a caspase-independent manner in vitro and in a xenograft model in vivo. We demonstrate that single amino acid deprivation by ADI is able to trigger autophagy. Inhibition of autophagy by chloroquine and siRNA enhances and accelerates ADI-induced cell death, suggesting that autophagy is a protective response to ADI, at least in the early phases. In addition, the co-administration of docetaxel, a caspase-dependent chemotherapy, with ADI inhibits tumor growth in vivo. Thus, targeting multiple cell death pathways, either through autophagy modulation or non-canonical apoptosis, may find expanded use as adjuvant chemotherapies, providing additional avenues for cancer treatment.

KW - Arginine deiminase

KW - Arginine deprivation

KW - Autophagy

KW - Caspase-independent apoptosis

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=66349091716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349091716&partnerID=8YFLogxK

U2 - 10.4161/auto.5.4.8252

DO - 10.4161/auto.5.4.8252

M3 - Article

C2 - 19276647

AN - SCOPUS:66349091716

VL - 5

SP - 567

EP - 568

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 4

ER -